JCR Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 10.84% vs -29.72% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 203.23% vs -94.64% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,966.00",
          "val2": "8,991.00",
          "chgp": "10.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "605.00",
          "val2": "-1,379.00",
          "chgp": "143.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "90.00",
          "val2": "151.00",
          "chgp": "-40.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "1,882.00",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "376.00",
          "val2": "124.00",
          "chgp": "203.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.60%",
          "val2": "-215.50%",
          "chgp": "22.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 21.91% vs -22.86% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 150.20% vs -179.41% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40,319.00",
          "val2": "33,072.00",
          "chgp": "21.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,988.00",
          "val2": "-3,036.00",
          "chgp": "198.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "398.00",
          "val2": "155.00",
          "chgp": "156.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1,882.00",
          "val2": "1,064.00",
          "chgp": "76.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,207.00",
          "val2": "-4,396.00",
          "chgp": "150.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.70%",
          "val2": "-193.80%",
          "chgp": "20.45%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

9,966.00

8,991.00

10.84%

Operating Profit (PBDIT) excl Other Income

605.00

-1,379.00

143.87%

Interest

90.00

151.00

-40.40%

Exceptional Items

0.00

1,882.00

-100.00%

Consolidate Net Profit

376.00

124.00

203.23%

Operating Profit Margin (Excl OI)

6.60%

-215.50%

22.21%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 10.84% vs -29.72% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 203.23% vs -94.64% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

40,319.00

33,072.00

21.91%

Operating Profit (PBDIT) excl Other Income

2,988.00

-3,036.00

198.42%

Interest

398.00

155.00

156.77%

Exceptional Items

1,882.00

1,064.00

76.88%

Consolidate Net Profit

2,207.00

-4,396.00

150.20%

Operating Profit Margin (Excl OI)

10.70%

-193.80%

20.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is 21.91% vs -22.86% in Mar 2025

Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 150.20% vs -179.41% in Mar 2025

All Annual Results